Europlasma S.A., a company specializing in plasma solutions, renewable energies, and asbestos waste treatment, has recently taken significant legal steps to address financial and operational challenges faced by its subsidiary, FDB Industries. The company, which operates primarily in France, has requested the court in Lorient to initiate a judicial rehabilitation procedure for FDB Industries. This request comes in the wake of a series of operational setbacks that have severely impacted the subsidiary’s financial stability and production capabilities.
Founded in 1992 and headquartered in Pessac, France, Europlasma is listed on the NYSE Euronext Paris stock exchange. The company is known for its expertise in providing plasma solutions for gas and hazardous waste treatment, generating electricity from waste and biomass gasification, and managing the destruction and valorization of asbestos waste. Despite its established presence in the industry, recent events have posed significant challenges to its operations.
The operational difficulties began with an incident in January that led to a halt in production at FDB Industries’ Fonderie de Bretagne facility. Efforts to resume production on schedule in June were unsuccessful, resulting in a prolonged stoppage. This disruption has placed considerable strain on the subsidiary’s liquidity, pushing Europlasma to the limits of its financial support capabilities.
In response to these challenges, Europlasma has formally requested the court to open a judicial rehabilitation procedure for FDB Industries. The primary objective of this procedure is to establish a protective framework that will facilitate the conditions necessary for restarting production. Additionally, the procedure aims to secure the long-term viability of the facility and enable the subsidiary to gradually regain its market share.
Europlasma remains committed to preserving jobs and reindustrializing the site. The company is also exploring new development opportunities, particularly within the defense sector, as it awaits the court’s decision. This strategic focus underscores Europlasma’s dedication to overcoming current challenges and ensuring the continued growth and sustainability of its operations.
For more information about Europlasma’s activities and initiatives, interested parties can visit their website at www.europlasma.com .
